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Oxidative stress features in important biological scenar-
ios such as the etiology of disease (e.g., Alzheimer’s
Disease), toxicology, aging, and signal transduction. It
can result in structural alterations of biomolecules
which, in turn, can disrupt biological function. More
than 70% of reactive oxygen species are absorbed by
proteins, resulting in a wide variety of structural mod-
ifications. Thus, oxidative stress has the potential to
introduce extensive complexity into the proteome, and
redox proteomics focuses on using proteomics methods
to elucidate redox-modulated changes to the proteome.
Such studies can include looking at changes in levels of
specific proteins within the proteome or probing post-
translational redox-based changes in protein structure.
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(J Am Soc Mass Spectrom 2007, 18, 588)This book is divided logically into three parts: oxi-
datively modified proteins and proteomic technologies;
cellular aspects of protein oxidation; and redox proteom-
ics analysis in human diseases. The chapters, which are
written by experts in each topic, could be read as clear,
comprehensive, and stand-alone critical reviews. How-
ever, the editors have chosen their topics well and assem-
bled the chapters so they amount to more than the sum of
their parts.
Part 1 maintains a balance between describing new
methodology and the fundamental context in which the
technology is applied. There is much of interest on the
mass spectrometer, including MS approaches to oxida-
tively/nitrosatively modified proteins, glycosylation,
multidimensional protein identification technology
(MudPIT), protein thiols, nitrosothiols, and nitrosoty-
rosines.
Part 2 is not quite as comprehensive. However, the
chapter by Aimee Lander et al. exploring the poten-
tial of thiol reactive lipid oxidation products in cell
signalling is very thought-provoking. Chapter 15
(Thomas Nyström) explores how protein carbonyla-
tion relates to senescence in microbial systems and
draws lessons for aging in higher organisms. Intrigu-
ingly, carbonylation seems to be kept low in all
organisms at the reproductive life-cycle stage thus
ensuring “fitness” of offspring.
Part 3 surveys applications of redox proteomics in
studies of biomarkers of human disease, oxidized pro-
teins in aging, Alzheimer’s disease, vascular disease,
diabetes, pre-eclampsia, and chronic airway diseases
such as asthma. These studies make clear that redox
proteomics will be a key arena for MSmethods in future
clinical research.
At 944 pages, this is a major book, which does credit
to the editors. I think readers interested in mass spec-
trometry methods in proteomics will find much that isvance to these studies. of interest here.r Inc.
